What is Controlant?
Controlant operates at the intersection of logistics and life sciences, providing a comprehensive digital platform designed to ensure the integrity of temperature-sensitive pharmaceutical products. By leveraging real-time visibility, automated monitoring, and data-driven insights, the company addresses the systemic inefficiencies that lead to product spoilage and waste. Its market position is defined by a commitment to sustainability and operational excellence, enabling global partners to navigate complex regulatory environments while minimizing their environmental footprint. Through the integration of IoT-enabled hardware and cloud-based software, Controlant facilitates a transparent, end-to-end view of the supply chain, which is essential for maintaining the efficacy of vaccines and high-value medications during transit.
How much funding has Controlant raised?
Controlant has raised a total of $17.5M across 2 funding rounds:
Unspecified
$2.5M
Series B
$15M
Unspecified (2016): $2.5M with participation from Frumtak Investment Fund
Series B (2020): $15M, investors not publicly disclosed
Key Investors in Controlant
Frumtak Investment Fund
Frumtak Ventures is an early-stage venture capital fund based in Iceland that invests in local innovation with global potential. The firm focuses on supporting founders who have shown early traction and the capability for international growth.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Controlant?
With the successful completion of its latest financing round, Controlant is well-positioned to scale its enterprise-level operations and expand its global footprint. The strategic focus will likely shift toward enhancing its proprietary software ecosystem and deepening its integration capabilities with existing pharmaceutical distribution networks. As the industry continues to prioritize resilience and sustainability, Controlant is poised to capitalize on the growing demand for automated, data-centric supply chain solutions. Future growth initiatives will likely involve further investment in predictive analytics and machine learning to preemptively identify and mitigate risks within the cold chain, thereby reinforcing its status as an indispensable partner for global healthcare organizations seeking to optimize their logistics performance and achieve long-term sustainability goals.
See full Controlant company page
